ARG1 and airway hyperresponsiveness: Although there appeared to be a trend indicating that Arg1 siRNA delivery via a gene delivery vehicle that combined isoprenaline with PEI (Fig. 5F, R) resulted in greater inhibition of airway hyperresponsiveness than scrambled siRNA delivered via the same vehicle (Fig. 5F, S), that difference did not attain statistical significance.